Home › Funds › Renaissance Technologies › CVM
Renaissance Technologies position in CVM
CEL-SCI CORP · Health Care
Latest position (Q2 2026)572.46K sh
Reported value held$595.36K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 772.88K | $3.04M | New |
| Q2 2022 | 218.88K | $985.00K | Reduce |
| Q3 2022 | 13.18K | $41.00K | Reduce |
| Q4 2022 | 24.02K | $56 | Add |
| Q4 2023 | 39.70K | $108 | New |
| Q1 2024 | 133.80K | $256 | Add |
| Q2 2024 | 173.80K | $201.61K | Add |
| Q4 2025 | 15.41K | $81.04K | New |
| Q1 2026 | 35.89K | $115.21K | Add |
| Q2 2026 | 572.46K | $595.36K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CVM
- Vanguard Group 285.12K sh · $1.50M · Q4 2025
- Citadel Advisors 198.50K sh · $206.44K · Q2 2026
- Geode Capital Management 88.20K sh · $91.78K · Q2 2026
- BlackRock Inc 43.26K sh · $44.99K · Q2 2026
- Bank of America Corp 40.92K sh · $42.55K · Q2 2026
- Northern Trust Corp 21.08K sh · $21.93K · Q2 2026
- UBS Group AG 8.03K sh · $8.35K · Q2 2026
- Morgan Stanley 41 sh · $43 · Q2 2026
- JPMorgan Chase & Co 7 sh · $8 · Q2 2026